Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1734554rdf:typepubmed:Citationlld:pubmed
pubmed-article:1734554lifeskim:mentionsumls-concept:C0042232lld:lifeskim
pubmed-article:1734554lifeskim:mentionsumls-concept:C1522570lld:lifeskim
pubmed-article:1734554lifeskim:mentionsumls-concept:C0000854lld:lifeskim
pubmed-article:1734554lifeskim:mentionsumls-concept:C0040613lld:lifeskim
pubmed-article:1734554lifeskim:mentionsumls-concept:C0039288lld:lifeskim
pubmed-article:1734554pubmed:issue3lld:pubmed
pubmed-article:1734554pubmed:dateCreated1992-2-28lld:pubmed
pubmed-article:1734554pubmed:abstractTextTranexamic acid (TA), an antifibrinolytic drug, is usually administered orally to women with menorrhagia. This route of administration is associated with adverse side-effects, therefore tampons impregnated with TA were used to assess the absorption of the drug across the vaginal epithelium. Blood levels of TA in group A (9 patients), who had one tampon inserted, and group B (10 patients), who had a tampon inserted at 2-hourly intervals so that a total of 3 tampons were administered over a 6-hour period, demonstrated absorption of the drug into the blood stream in low concentrations.lld:pubmed
pubmed-article:1734554pubmed:languageenglld:pubmed
pubmed-article:1734554pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1734554pubmed:citationSubsetIMlld:pubmed
pubmed-article:1734554pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1734554pubmed:statusMEDLINElld:pubmed
pubmed-article:1734554pubmed:monthFeblld:pubmed
pubmed-article:1734554pubmed:issn0256-9574lld:pubmed
pubmed-article:1734554pubmed:authorpubmed-author:CohenMMlld:pubmed
pubmed-article:1734554pubmed:authorpubmed-author:MoodleyJJlld:pubmed
pubmed-article:1734554pubmed:authorpubmed-author:DuttonMMlld:pubmed
pubmed-article:1734554pubmed:authorpubmed-author:DevrajKKlld:pubmed
pubmed-article:1734554pubmed:issnTypePrintlld:pubmed
pubmed-article:1734554pubmed:day1lld:pubmed
pubmed-article:1734554pubmed:volume81lld:pubmed
pubmed-article:1734554pubmed:ownerNLMlld:pubmed
pubmed-article:1734554pubmed:authorsCompleteYlld:pubmed
pubmed-article:1734554pubmed:pagination150-2lld:pubmed
pubmed-article:1734554pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1734554pubmed:meshHeadingpubmed-meshheading:1734554-...lld:pubmed
pubmed-article:1734554pubmed:meshHeadingpubmed-meshheading:1734554-...lld:pubmed
pubmed-article:1734554pubmed:meshHeadingpubmed-meshheading:1734554-...lld:pubmed
pubmed-article:1734554pubmed:meshHeadingpubmed-meshheading:1734554-...lld:pubmed
pubmed-article:1734554pubmed:meshHeadingpubmed-meshheading:1734554-...lld:pubmed
pubmed-article:1734554pubmed:meshHeadingpubmed-meshheading:1734554-...lld:pubmed
pubmed-article:1734554pubmed:meshHeadingpubmed-meshheading:1734554-...lld:pubmed
pubmed-article:1734554pubmed:meshHeadingpubmed-meshheading:1734554-...lld:pubmed
pubmed-article:1734554pubmed:year1992lld:pubmed
pubmed-article:1734554pubmed:articleTitleVaginal absorption of low-dose tranexamic acid from impregnated tampons.lld:pubmed
pubmed-article:1734554pubmed:affiliationDepartment of Obstetrics and Gynaecology, University of Natal.lld:pubmed
pubmed-article:1734554pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1734554pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:1734554pubmed:publicationTypeRandomized Controlled Triallld:pubmed